ASPIRE FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

TIMOTHY M BATEMAN

Phone

8165312842

Tax Period

2018-01-01 to 2018-12-31

ASPIRE FOUNDATION, founded in 2006, is a small nonprofit that reported $155K in total revenue in fiscal year 2018. Revenue surged 35% from the prior year, signaling strong growth momentum.

Mission

THE PRIMARY PURPOSE OF ASPIRE FOUNDATION IS TO CONDUCT MEDICAL RESEARCH IN ACADEMIC AND CLINICAL SETTINGS AND TO PUBLISH AND MAKE AVAILABLE TO THE MEDICAL COMMUNITY AND THE GENERAL PUBLIC THE RESULTS OF SUCH MEDICAL RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $60,301 Revenue: $60,301

CHARACTERIZATION OF CHANGES IN VENTRICULAR MECHANICS IN RESPONSE TO LEXISCANTM STRESS USING TAGGED CINE CARDIAC MAGNETIC RESONANCE IMAGING AKA ASTELLAS TAGGING:THE PURPOSE OF THIS RESEARCH STUDY IS TO QUANTIFY THE EFFECTS OF LEXISCAN (REGADENOSON) ON MYOCARDIAL FUNCTION AND CONTRACTION IN THE PRESENCE OF CORONARY ARTERY DISEASE UTILIZING CARDIAC MRI. ONE SUBJECT WAS ENROLLED IN 2018, COMPLETING ENROLLMENT. THE STUDY CLOSED AT THE IRB IN 2018.

Program 2

Expenses: $53,778 Revenue: $56,088

PET/SPECT:THIS PROSPECTIVE, RANDOMIZED TRIAL IS COMPARING SPECT AGAINST PET FOR PATIENT WITH KNOWN CORONARY ARTERY DISEASE AND NEW OR WORSENING SYMPTOMS. ENROLLMENT ENDED IN SEPTEMBER OF 2013 AND THE 12-MONTH FOLLOW-UP WAS COMPLETED IN OCTOBER OF 2014. IN 2018, A MANUSCRIPT WAS SUBMITTED FOR PUBLICATION IN THE JACC.

Program 3

Expenses: $30,291 Revenue: $30,291

A PILOT INVESTIGATION DETECTING CRYOABLATION SCAR BY 3D LATE GADOLINIUM ENHANCEMENT - AKA LAMDE: THE PURPOSE OF THIS STUDY IS TO MEASURE THE SUCCESS OF A CRYOABLATION PRODUCED UTILIZING CARDIAC...

A PILOT INVESTIGATION DETECTING CRYOABLATION SCAR BY 3D LATE GADOLINIUM ENHANCEMENT - AKA LAMDE: THE PURPOSE OF THIS STUDY IS TO MEASURE THE SUCCESS OF A CRYOABLATION PRODUCED UTILIZING CARDIAC MAGNETIC RESONANCE IMAGING. THREE SUBJECTS WERE ENROLLED IN 2018, COMPLETING ENROLLMENT. THE STUDY CLOSED AT THE IRB IN 2018.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $155,194

Program Service Revenue $0

Investment Income $289

Other Revenue $0

TOTAL REVENUE $155,483

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $153,173

Other Expenses $155,483

TOTAL EXPENSES $155,483

Year-over-Year Comparison

	2018	2017	Change
Revenue	$155,483	$114,785	+0.4%
Expenses	$155,483	$114,785	+0.4%
Net Income	$0	$0	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
TIMOTHY M BATEMAN MD	MEDICAL DIRECTOR/DIRECTOR	5.00	Officer Director	$0	$0	$0
KENNETH C HUBER MD	DIRECTOR	1.00	Director	$0	$0	$0
JAMES A CASE	DIRECTOR	7.00	Director	$0	$0	$0
IBRAHIM SAEED MD	DIRECTOR	1.00	Director	$0	$0	$0
RON CODA	TREASURER	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$155,483	$155,483	$35,786	No data